Pfizer's SVP and Head of Medicine Design, Charlotte Allerton, joins this episode of "Making Sense of Science" to share timely insights on this important breakthrough, including how the pill works,  the impressive results of the recent studies,  its encouraging profile against Omicron, and why it could alter the trajectory of the pandemic in 2022.